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Abstract
Background: We investigated the prevalence of post-procedural headache in patients who have undergone
thrombectomy for ischemic stroke, and correlated history of migraine with risk of peri-procedural complications.
A total of 314 patients underwent thrombectomy at the Danish National Hospital from January 2012 to December
2014. Eligible subjects were phone-interviewed using a purpose-developed semi-structured questionnaire according
to the International Classification of Headache Disorders 3, beta version criteria.
Findings: Among 96 eligible subjects, there was a significant decrease in migraine (p = 0.022) within the first 3
months after EVT compared to 1 year before treatment, which was further evident at interview time (on average 1.6
years after EVT, p = 0.013). A minority of patients experienced headaches for the first time within 3 months of their
EVT (migraine 2, TTH 9), which persisted at interview time for subjects with migraine. Out of 12 subjects with
peri-procedural complications, 2 had a history of migraine with aura.
Conclusion: Thrombectomy leads to a significant decrease in previously known migraine, and new onset of
headache in a small subset of patients. A history of migraine does not appear to predispose to peri-procedural
complications.
Keywords: EVT, Stroke, Risk, Complications, Migraine
Introduction
Endovascular thrombectomy is an established procedure
used to treat ischemic stroke. The risk of post-procedural
headache has received little attention. Studies on the inter-
play between headache and endovascular treatment (EVT)
are contradictory [1–3]. It is also unknown whether peri-
procedural vascular complications are more prevalent in
subjects with migraine history, or how such complications
may affect headache patterns after EVT. To elucidate po-
tential bidirectional links between endovascular thromb-
ectomy, procedure-related complications, and headache
we retrospectively assessed headache characteristics in a
cohort of patients with ischemic stroke who had under-
gone thrombectomy.
Methods
We identified all patients who had undergone EVT for
ischemic stroke at a tertiary referral center, Copenhagen,
Denmark between January 2012 and December 2014. We
assessed medical records of all identified cases (n = 314)
and excluded those with: 1) procedures other than
thrombectomy, and 2) aphasia, or no command of Danish
or English.
Eligible patients were phone interviewed once, on average
1.6 years (range: 0.2–3.0) after EVT, using a purpose-
developed semi-structured questionnaire. We collected infor-
mation on headache status 1 year and 1 month before EVT
and after EVT (3 months after and at time of interview).
All headaches were classified according to the Inter-
national Classification of Headache Disorders 3, beta
version [4].
Frequencies and percentages were calculated for categor-
ical variables and medians and range for continuous vari-
ables. For comparisons of categorical data, we used the
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McNemar test. All p-values were two-sided and p-values
below 0.05 were considered statistically significant. All ana-
lyses were performed using IBM® SPSS® Statistics version 23.
Findings
In total, ninety-six patients were eligible and included in
the study (Table 1). Twenty-five subjects (26%) reported
lifetime history of migraine, 14 of these (15%) had mi-
graine with aura, and 25 subjects (26%) reported lifetime
history of tension-type headache (TTH). One year prior
to thrombectomy, sixteen subjects (17%) reported mi-
graine, 11 of these (12%) had migraine with aura, and 15
subjects (16%) reported TTH.
Headache status before and after EVT
We found a significant decrease (56%) in migraine 3 months
after thrombectomy compared to 1 year before the proced-
ure (7 versus 16 subjects, p = 0.022) (Fig. 1, Additional file
1: Table S1). At “time of interview” (on average 1.6 years
after EVT) we observed a larger (63%) reduction yet (6 ver-
sus 16 subjects, p = 0.013). For this time window, we saw
no change in TTH.
We also compared patients’ headache status 1 month be-
fore thrombectomy with 3 months after treatment. Here we
found an increase in TTH (6 versus 16 subjects, p= 0.013),
which persisted at interview time (6 versus 19 subjects, p=
0.002). For this time window, we saw no change in migraine.
De novo headaches after EVT
Nine subjects reported new onset of tension-type like
headache during the first 3 months after EVT (6 episodic,
3 chronic) (Fig. 2). By time of interview, only 6 patients
still experienced these new headaches (1 chronic, 4 epi-
sodic, 1 data not available).
Two female subjects experienced de novo migraine-
like headache (one with and one without aura, ages 45
and 90 years) within the first 3 months after EVT, both
reporting persistent headache at interview time, 2.1 and
1.3 years after EVT, respectively.
Peri-procedural complications during EVT
In 12 of 96 subjects (12.5%), the thrombectomy procedure
was complicated (Additional file 1: Figure S1 and Table
S2). Peri-procedural complications arose in 8% of patients
with a pre-EVT history of migraine (2 patients with
migraine with aura) and 14% of patients with no history of
migraine (n = 10).
Discussion
Considering the focal intravascular manipulation inflicted
on the vessels, headache after thrombectomy seems likely
due to endothelial injury-induced inflammation of the
intracranial vessel walls, activating sensory afferents. In
support, a recent 3 T vessel wall MRI study reported con-
trast enhancement in arterial walls in patients treated with
stent-retriever thrombectomy [5]. The bidirectional link
between headache and EVT has thus far never been inves-
tigated, hence it is unknown whether history of headache
may influence the endovascular procedure due to vascular
complications such as distal embolization or dissection
(Additional file 1: Table S2), and vice versa whether a
complicated procedure may affect headache patterns after
EVT. Studies on familial hemiplegic migraine type-1
mutant mice show larger infarcts and worse neurological
outcomes after stroke compared to wild-type mice [6],
specifically suggesting that a diagnosis of migraine with
aura may predispose to vascular complications during the
thrombectomy procedure.
As a major finding, we report a significant drop in mi-
graine prevalence after thrombectomy for subjects with
pre-EVT history of migraine, resulting in prevalence esti-
mates close to those for the general population. We lacked
a control group to assess for decline in migraine prevalence
over time irrespective of EVT. However, we believe that the
reduction of migraine observed in our study is beyond what
one would expect from the natural history of this disorder
Table 1 Clinical and demographic data in 96 stroke patients
Characteristics
Median age at EVT (years) 67 years (range: 28–90)
Males (n) 55
Right-handed (n) 87
Median height (cm) 174 cm (range: 152–194)
Median weight (kg) 75 kg (range: 45–130)
Smokers (n) 60
Median pack yearsa 20 years (range: 1–92)
History of hypertension (n) 38
Medication history prior to EVT (n)
- Antithrombotic therapyb
- Antihypertensive therapyc
28d
38e
Medication status at interview time (n)
- Antithrombotic therapyb
- Antihypertensive therapyc
80
52
Thrombolysis treatment for stroke (n) 69f
Procedures performed (n)
- Thrombectomy
- Thrombectomy + stent
- Thrombectomy + coil + Onyx
89
6
1
Median time from procedure to
interview (years)
1.6 years (range: 0.2–3.0)
aPack year = defined as 20 cigarettes smoked every day for one year
bAntithrombotic medication included clopidogrel (n = 5), acetylsalicylic acid
(n = 17), warfarin (n = 5), rivaroxaban (n = 1) and dabigatran (n = 1)
cAntihypertensive medication included angiotensin-II-inhibitors (n = 8),
beta-blockers (n = 20), ACE inhibitors (n = 10), and calcium-antagonists (n = 7)
d8 missing records
e7 missing records
f3 missing records
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[7]. This decrease could also be explained by the initi-
ation of antithrombotic medication after thrombectomy
[8]. No new prophylactic migraine treatment was initi-
ated after EVT.
Contrary to migraine, we found that thrombectomy led
to an increase in TTH after EVT, with a significantly larger
prevalence compared to 1 month prior to treatment. How-
ever, when comparing the post-procedural prevalence with
1-year prior to thrombectomy, we observed no change,
suggesting that thrombectomy does not result in added
headache burden in the larger scope of life-time headache
evolution. Differences in post-procedural medication (such
as antithrombotic treatment) cannot explain this disparity
between migraine and TTH, as all subjects were started on
antithrombotic treatment after thrombectomy.
We also report new onset of headache in a subset of
subjects (11%) who undergo thrombectomy. This
headache resolves over time for some TTH cases, but
persists for those reporting de novo migraine, suggesting
that a fraction (8%) of subjects treated with thrombec-
tomy may develop persistent new headache. Any de novo
headache that occurs with close temporal relation to
EVT is per definition a secondary headache, however,
the current ICHD-3 beta criteria only allow any such
headache to last up to 24 h [4]. This taxonomy is inad-
equate, as post-thrombectomy headache for the majority
lasts at least 3 months, if not longer. Also, our results
confirm the accepted notion that migraine with aura is
overrepresented in a stroke cohort compared to the
general population [9], and may even be larger in our
cohort compared to other stroke case-based studies [10].
Finally, our results show that 12.5% of subjects under-
going thrombectomy experience peri-procedural compli-
cations. Albeit underpowered, these data suggest that
Fig. 1 Headache status before and after thrombectomy. Numbers represent patients. Dotted line represents endovascular procedure.
MA =migraine with aura, MO =migraine without aura
Fig. 2 Distribution of de novo and known headache after thrombectomy. Numbers represent patients. TTH = tension-type headache
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migraine with aura does not increase the risk of compli-
cations during thrombectomy.
In conclusion, we have presented the first report of
headache onset and prevalence after thrombectomy.
Strengths of the study include a homogenous patient
group, direct phone interviews, and ICHD-3 beta classifi-
cation [5]. Limitations include recall bias and a relatively
small sample size. Nevertheless, we believe the data help
improve our understanding of post-procedural headache
to optimize counseling of subjects who undergo thromb-
ectomy with resultant headache. Larger, statistically robust
prospective studies are warranted to establish the direc-
tion and magnitude of changes in migraine and other
headaches after thrombectomy and to further explore mi-
graine as a risk factor for peri-procedural complications.
Additional file
Additional file 1: Table S1. Headache status before and after
thrombectomy. Median time from endovascular treatment to interview:
1.6 years (range 0.2–3.0). Table S2. Classification system of peri-procedural
complications. Figure S1. Peri-procedural complications in subjects with a
life-time history of migraine. (DOCX 132 kb)
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